April 14, 2008 - Boston Scientific Corp. reported that the Japanese Ministry of Health, Labor and Welfare (MHLW) approved ACUITY Steerable left ventricular lead for use with cardiac resynchronization therapy (CRT) devices, which treat heart failure.
The Company, which also received reimbursement approval for the lead from the National Health Insurance System, plans to launch the product immediately in Japan.
